aluates Reports

$ 0.0

Automative

Global Antihormonal Cancer Therapies Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-6D14299

Global Antihormonal Cancer Therapies Market Research Report 2023

BUY CHAPTERS

Global Antihormonal Cancer Therapies Market Insights, Forecast to 2030

Code: QYRE-Auto-6D14299

Report

December 2024

Pages:129

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Novartis

Pfizer Inc

Sanofi

Takeda

Roche

Amgen Inc

Samyang Biopharmaceuticals

Tolmar

Bluebird bio

Bristol–Myers Squibb

Exelixis Inc

Guardant Health

Illumina Inc

Merck KGaA

AbbVie

Gilead Sciences

Johnson & Johnson

Eli Lilly

Astellas

Merck

Bayer

Antihormonal Cancer Therapies Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antihormonal Cancer Therapies Market

Antihormonal Cancer Therapy is a treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors.

Market Analysis and Insights: Global Antihormonal Cancer Therapies Market

The global Antihormonal Cancer Therapies market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Antihormonal Cancer Therapies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antihormonal Cancer Therapies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antihormonal Cancer Therapies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antihormonal Cancer Therapies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antihormonal Cancer Therapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antihormonal Cancer Therapies revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Antihormonal Cancer Therapies Market Report

Report Metric	Details
Report Name	Antihormonal Cancer Therapies Market
CAGR	5%
Segment by Type	Radiations Drugs Surgeries Others
Segment by Application	Breast Cancer Prostate Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Samyang Biopharmaceuticals, Tolmar, Bluebird Bio, Bristol-Myers Squibb, Exelixis, Guardant Health, Illumina, Novartis, Merck KGaA, AbbVie, Gilead Sciences, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co., Sanofi, Bayer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antihormonal Cancer Therapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antihormonal Cancer Therapies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antihormonal Cancer Therapies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Antihormonal Cancer Therapies Market report?

Ans: The main players in the Antihormonal Cancer Therapies Market are Roche, Amgen, Samyang Biopharmaceuticals, Tolmar, Bluebird Bio, Bristol-Myers Squibb, Exelixis, Guardant Health, Illumina, Novartis, Merck KGaA, AbbVie, Gilead Sciences, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co., Sanofi, Bayer

What are the Application segmentation covered in the Antihormonal Cancer Therapies Market report?

Ans: The Applications covered in the Antihormonal Cancer Therapies Market report are Breast Cancer, Prostate Cancer, Other

What are the Type segmentation covered in the Antihormonal Cancer Therapies Market report?

Ans: The Types covered in the Antihormonal Cancer Therapies Market report are Radiations, Drugs, Surgeries, Others

Recommended Reports

Cancer Therapy Markets

Prostate Cancer Markets

Cancer Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Radiations

1.2.3 Drugs

1.2.4 Surgeries

1.2.5 Others

1.3 Market by Application

1.3.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antihormonal Cancer Therapies Market Perspective (2019-2030)

2.2 Global Antihormonal Cancer Therapies Growth Trends by Region

2.2.1 Antihormonal Cancer Therapies Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Antihormonal Cancer Therapies Historic Market Size by Region (2019-2024)

2.2.3 Antihormonal Cancer Therapies Forecasted Market Size by Region (2025-2030)

2.3 Antihormonal Cancer Therapies Market Dynamics

2.3.1 Antihormonal Cancer Therapies Industry Trends

2.3.2 Antihormonal Cancer Therapies Market Drivers

2.3.3 Antihormonal Cancer Therapies Market Challenges

2.3.4 Antihormonal Cancer Therapies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Antihormonal Cancer Therapies by Players

3.1.1 Global Antihormonal Cancer Therapies Revenue by Players (2019-2024)

3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2019-2024)

3.2 Global Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Antihormonal Cancer Therapies, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Antihormonal Cancer Therapies Market Concentration Ratio

3.4.1 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antihormonal Cancer Therapies Revenue in 2023

3.5 Global Key Players of Antihormonal Cancer Therapies Head office and Area Served

3.6 Global Key Players of Antihormonal Cancer Therapies, Product and Application

3.7 Global Key Players of Antihormonal Cancer Therapies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antihormonal Cancer Therapies Breakdown Data by Type

4.1 Global Antihormonal Cancer Therapies Historic Market Size by Type (2019-2024)

4.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2025-2030)

5 Antihormonal Cancer Therapies Breakdown Data by Application

5.1 Global Antihormonal Cancer Therapies Historic Market Size by Application (2019-2024)

5.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Antihormonal Cancer Therapies Market Size (2019-2030)

6.2 North America Antihormonal Cancer Therapies Market Size by Type

6.2.1 North America Antihormonal Cancer Therapies Market Size by Type (2019-2024)

6.2.2 North America Antihormonal Cancer Therapies Market Size by Type (2025-2030)

6.2.3 North America Antihormonal Cancer Therapies Market Share by Type (2019-2030)

6.3 North America Antihormonal Cancer Therapies Market Size by Application

6.3.1 North America Antihormonal Cancer Therapies Market Size by Application (2019-2024)

6.3.2 North America Antihormonal Cancer Therapies Market Size by Application (2025-2030)

6.3.3 North America Antihormonal Cancer Therapies Market Share by Application (2019-2030)

6.4 North America Antihormonal Cancer Therapies Market Size by Country

6.4.1 North America Antihormonal Cancer Therapies Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Antihormonal Cancer Therapies Market Size by Country (2019-2024)

6.4.3 North America Antihormonal Cancer Therapies Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Antihormonal Cancer Therapies Market Size (2019-2030)

7.2 Europe Antihormonal Cancer Therapies Market Size by Type

7.2.1 Europe Antihormonal Cancer Therapies Market Size by Type (2019-2024)

7.2.2 Europe Antihormonal Cancer Therapies Market Size by Type (2025-2030)

7.2.3 Europe Antihormonal Cancer Therapies Market Share by Type (2019-2030)

7.3 Europe Antihormonal Cancer Therapies Market Size by Application

7.3.1 Europe Antihormonal Cancer Therapies Market Size by Application (2019-2024)

7.3.2 Europe Antihormonal Cancer Therapies Market Size by Application (2025-2030)

7.3.3 Europe Antihormonal Cancer Therapies Market Share by Application (2019-2030)

7.4 Europe Antihormonal Cancer Therapies Market Size by Country

7.4.1 Europe Antihormonal Cancer Therapies Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Antihormonal Cancer Therapies Market Size by Country (2019-2024)

7.4.3 Europe Antihormonal Cancer Therapies Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Antihormonal Cancer Therapies Market Size (2019-2030)

8.2 China Antihormonal Cancer Therapies Market Size by Type

8.2.1 China Antihormonal Cancer Therapies Market Size by Type (2019-2024)

8.2.2 China Antihormonal Cancer Therapies Market Size by Type (2025-2030)

8.2.3 China Antihormonal Cancer Therapies Market Share by Type (2019-2030)

8.3 China Antihormonal Cancer Therapies Market Size by Application

8.3.1 China Antihormonal Cancer Therapies Market Size by Application (2019-2024)

8.3.2 China Antihormonal Cancer Therapies Market Size by Application (2025-2030)

8.3.3 China Antihormonal Cancer Therapies Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Antihormonal Cancer Therapies Market Size (2019-2030)

9.2 Asia Antihormonal Cancer Therapies Market Size by Type

9.2.1 Asia Antihormonal Cancer Therapies Market Size by Type (2019-2024)

9.2.2 Asia Antihormonal Cancer Therapies Market Size by Type (2025-2030)

9.2.3 Asia Antihormonal Cancer Therapies Market Share by Type (2019-2030)

9.3 Asia Antihormonal Cancer Therapies Market Size by Application

9.3.1 Asia Antihormonal Cancer Therapies Market Size by Application (2019-2024)

9.3.2 Asia Antihormonal Cancer Therapies Market Size by Application (2025-2030)

9.3.3 Asia Antihormonal Cancer Therapies Market Share by Application (2019-2030)

9.4 Asia Antihormonal Cancer Therapies Market Size by Region

9.4.1 Asia Antihormonal Cancer Therapies Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Antihormonal Cancer Therapies Market Size by Region (2019-2024)

9.4.3 Asia Antihormonal Cancer Therapies Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Type

10.2.1 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Application

10.3.1 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Country

10.4.1 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Antihormonal Cancer Therapies Introduction

11.1.4 Roche Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Antihormonal Cancer Therapies Introduction

11.2.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.2.5 Amgen Recent Developments

11.3 Samyang Biopharmaceuticals

11.3.1 Samyang Biopharmaceuticals Company Details

11.3.2 Samyang Biopharmaceuticals Business Overview

11.3.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Introduction

11.3.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.3.5 Samyang Biopharmaceuticals Recent Developments

11.4 Tolmar

11.4.1 Tolmar Company Details

11.4.2 Tolmar Business Overview

11.4.3 Tolmar Antihormonal Cancer Therapies Introduction

11.4.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.4.5 Tolmar Recent Developments

11.5 Bluebird Bio

11.5.1 Bluebird Bio Company Details

11.5.2 Bluebird Bio Business Overview

11.5.3 Bluebird Bio Antihormonal Cancer Therapies Introduction

11.5.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.5.5 Bluebird Bio Recent Developments

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Introduction

11.6.4 Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.6.5 Bristol-Myers Squibb Recent Developments

11.7 Exelixis

11.7.1 Exelixis Company Details

11.7.2 Exelixis Business Overview

11.7.3 Exelixis Antihormonal Cancer Therapies Introduction

11.7.4 Exelixis Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.7.5 Exelixis Recent Developments

11.8 Guardant Health

11.8.1 Guardant Health Company Details

11.8.2 Guardant Health Business Overview

11.8.3 Guardant Health Antihormonal Cancer Therapies Introduction

11.8.4 Guardant Health Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.8.5 Guardant Health Recent Developments

11.9 Illumina

11.9.1 Illumina Company Details

11.9.2 Illumina Business Overview

11.9.3 Illumina Antihormonal Cancer Therapies Introduction

11.9.4 Illumina Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.9.5 Illumina Recent Developments

11.10 Novartis

11.10.1 Novartis Company Details

11.10.2 Novartis Business Overview

11.10.3 Novartis Antihormonal Cancer Therapies Introduction

11.10.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.10.5 Novartis Recent Developments

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Antihormonal Cancer Therapies Introduction

11.11.4 Merck KGaA Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.11.5 Merck KGaA Recent Developments

11.12 AbbVie

11.12.1 AbbVie Company Details

11.12.2 AbbVie Business Overview

11.12.3 AbbVie Antihormonal Cancer Therapies Introduction

11.12.4 AbbVie Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.12.5 AbbVie Recent Developments

11.13 Gilead Sciences

11.13.1 Gilead Sciences Company Details

11.13.2 Gilead Sciences Business Overview

11.13.3 Gilead Sciences Antihormonal Cancer Therapies Introduction

11.13.4 Gilead Sciences Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.13.5 Gilead Sciences Recent Developments

11.14 Johnson & Johnson

11.14.1 Johnson & Johnson Company Details

11.14.2 Johnson & Johnson Business Overview

11.14.3 Johnson & Johnson Antihormonal Cancer Therapies Introduction

11.14.4 Johnson & Johnson Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.14.5 Johnson & Johnson Recent Developments

11.15 Pfizer

11.15.1 Pfizer Company Details

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Antihormonal Cancer Therapies Introduction

11.15.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.15.5 Pfizer Recent Developments

11.16 Takeda

11.16.1 Takeda Company Details

11.16.2 Takeda Business Overview

11.16.3 Takeda Antihormonal Cancer Therapies Introduction

11.16.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.16.5 Takeda Recent Developments

11.17 Eli Lilly

11.17.1 Eli Lilly Company Details

11.17.2 Eli Lilly Business Overview

11.17.3 Eli Lilly Antihormonal Cancer Therapies Introduction

11.17.4 Eli Lilly Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.17.5 Eli Lilly Recent Developments

11.18 AstraZeneca

11.18.1 AstraZeneca Company Details

11.18.2 AstraZeneca Business Overview

11.18.3 AstraZeneca Antihormonal Cancer Therapies Introduction

11.18.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.18.5 AstraZeneca Recent Developments

11.19 Astellas

11.19.1 Astellas Company Details

11.19.2 Astellas Business Overview

11.19.3 Astellas Antihormonal Cancer Therapies Introduction

11.19.4 Astellas Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.19.5 Astellas Recent Developments

11.20 Merck & Co.

11.20.1 Merck & Co. Company Details

11.20.2 Merck & Co. Business Overview

11.20.3 Merck & Co. Antihormonal Cancer Therapies Introduction

11.20.4 Merck & Co. Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.20.5 Merck & Co. Recent Developments

11.21 Sanofi

11.21.1 Sanofi Company Details

11.21.2 Sanofi Business Overview

11.21.3 Sanofi Antihormonal Cancer Therapies Introduction

11.21.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.21.5 Sanofi Recent Developments

11.22 Bayer

11.22.1 Bayer Company Details

11.22.2 Bayer Business Overview

11.22.3 Bayer Antihormonal Cancer Therapies Introduction

11.22.4 Bayer Revenue in Antihormonal Cancer Therapies Business (2019-2024)

11.22.5 Bayer Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Novartis

Pfizer Inc

Sanofi

Takeda

Roche

Amgen Inc

Samyang Biopharmaceuticals

Tolmar

Bluebird bio

Bristol–Myers Squibb

Exelixis Inc

Guardant Health

Illumina Inc

Merck KGaA

AbbVie

Gilead Sciences

Johnson & Johnson

Eli Lilly

Astellas

Merck

Bayer

List of Tables

Table 1. Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Radiations

Table 3. Key Players of Drugs

Table 4. Key Players of Surgeries

Table 5. Key Players of Others

Table 6. Global Antihormonal Cancer Therapies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Antihormonal Cancer Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Antihormonal Cancer Therapies Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Antihormonal Cancer Therapies Market Share by Region (2019-2024)

Table 10. Global Antihormonal Cancer Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Antihormonal Cancer Therapies Market Share by Region (2025-2030)

Table 12. Antihormonal Cancer Therapies Market Trends

Table 13. Antihormonal Cancer Therapies Market Drivers

Table 14. Antihormonal Cancer Therapies Market Challenges

Table 15. Antihormonal Cancer Therapies Market Restraints

Table 16. Global Antihormonal Cancer Therapies Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Antihormonal Cancer Therapies Revenue Share by Players (2019-2024)

Table 18. Global Top Antihormonal Cancer Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihormonal Cancer Therapies as of 2023)

Table 19. Global Antihormonal Cancer Therapies Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Antihormonal Cancer Therapies Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Antihormonal Cancer Therapies, Headquarters and Area Served

Table 22. Global Key Players of Antihormonal Cancer Therapies, Product and Application

Table 23. Global Key Players of Antihormonal Cancer Therapies, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Antihormonal Cancer Therapies Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2019-2024)

Table 27. Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2025-2030)

Table 29. Global Antihormonal Cancer Therapies Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Antihormonal Cancer Therapies Revenue Share by Application (2019-2024)

Table 31. Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Antihormonal Cancer Therapies Revenue Share by Application (2025-2030)

Table 33. North America Antihormonal Cancer Therapies Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Antihormonal Cancer Therapies Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Antihormonal Cancer Therapies Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Antihormonal Cancer Therapies Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Antihormonal Cancer Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Antihormonal Cancer Therapies Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Antihormonal Cancer Therapies Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Antihormonal Cancer Therapies Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Antihormonal Cancer Therapies Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Antihormonal Cancer Therapies Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Antihormonal Cancer Therapies Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Antihormonal Cancer Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Antihormonal Cancer Therapies Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Antihormonal Cancer Therapies Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Antihormonal Cancer Therapies Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Antihormonal Cancer Therapies Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Antihormonal Cancer Therapies Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Antihormonal Cancer Therapies Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Antihormonal Cancer Therapies Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Antihormonal Cancer Therapies Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Antihormonal Cancer Therapies Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Antihormonal Cancer Therapies Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Antihormonal Cancer Therapies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Antihormonal Cancer Therapies Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Antihormonal Cancer Therapies Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size by Country (2025-2030) & (US$ Million)

Table 65. Roche Company Details

Table 66. Roche Business Overview

Table 67. Roche Antihormonal Cancer Therapies Product

Table 68. Roche Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 69. Roche Recent Developments

Table 70. Amgen Company Details

Table 71. Amgen Business Overview

Table 72. Amgen Antihormonal Cancer Therapies Product

Table 73. Amgen Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 74. Amgen Recent Developments

Table 75. Samyang Biopharmaceuticals Company Details

Table 76. Samyang Biopharmaceuticals Business Overview

Table 77. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product

Table 78. Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 79. Samyang Biopharmaceuticals Recent Developments

Table 80. Tolmar Company Details

Table 81. Tolmar Business Overview

Table 82. Tolmar Antihormonal Cancer Therapies Product

Table 83. Tolmar Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 84. Tolmar Recent Developments

Table 85. Bluebird Bio Company Details

Table 86. Bluebird Bio Business Overview

Table 87. Bluebird Bio Antihormonal Cancer Therapies Product

Table 88. Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 89. Bluebird Bio Recent Developments

Table 90. Bristol-Myers Squibb Company Details

Table 91. Bristol-Myers Squibb Business Overview

Table 92. Bristol-Myers Squibb Antihormonal Cancer Therapies Product

Table 93. Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 94. Bristol-Myers Squibb Recent Developments

Table 95. Exelixis Company Details

Table 96. Exelixis Business Overview

Table 97. Exelixis Antihormonal Cancer Therapies Product

Table 98. Exelixis Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 99. Exelixis Recent Developments

Table 100. Guardant Health Company Details

Table 101. Guardant Health Business Overview

Table 102. Guardant Health Antihormonal Cancer Therapies Product

Table 103. Guardant Health Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 104. Guardant Health Recent Developments

Table 105. Illumina Company Details

Table 106. Illumina Business Overview

Table 107. Illumina Antihormonal Cancer Therapies Product

Table 108. Illumina Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 109. Illumina Recent Developments

Table 110. Novartis Company Details

Table 111. Novartis Business Overview

Table 112. Novartis Antihormonal Cancer Therapies Product

Table 113. Novartis Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 114. Novartis Recent Developments

Table 115. Merck KGaA Company Details

Table 116. Merck KGaA Business Overview

Table 117. Merck KGaA Antihormonal Cancer Therapies Product

Table 118. Merck KGaA Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 119. Merck KGaA Recent Developments

Table 120. AbbVie Company Details

Table 121. AbbVie Business Overview

Table 122. AbbVie Antihormonal Cancer Therapies Product

Table 123. AbbVie Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 124. AbbVie Recent Developments

Table 125. Gilead Sciences Company Details

Table 126. Gilead Sciences Business Overview

Table 127. Gilead Sciences Antihormonal Cancer Therapies Product

Table 128. Gilead Sciences Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 129. Gilead Sciences Recent Developments

Table 130. Johnson & Johnson Company Details

Table 131. Johnson & Johnson Business Overview

Table 132. Johnson & Johnson Antihormonal Cancer Therapies Product

Table 133. Johnson & Johnson Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 134. Johnson & Johnson Recent Developments

Table 135. Pfizer Company Details

Table 136. Pfizer Business Overview

Table 137. Pfizer Antihormonal Cancer Therapies Product

Table 138. Pfizer Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 139. Pfizer Recent Developments

Table 140. Takeda Company Details

Table 141. Takeda Business Overview

Table 142. Takeda Antihormonal Cancer Therapies Product

Table 143. Takeda Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 144. Takeda Recent Developments

Table 145. Eli Lilly Company Details

Table 146. Eli Lilly Business Overview

Table 147. Eli Lilly Antihormonal Cancer Therapies Product

Table 148. Eli Lilly Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 149. Eli Lilly Recent Developments

Table 150. AstraZeneca Company Details

Table 151. AstraZeneca Business Overview

Table 152. AstraZeneca Antihormonal Cancer Therapies Product

Table 153. AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 154. AstraZeneca Recent Developments

Table 155. Astellas Company Details

Table 156. Astellas Business Overview

Table 157. Astellas Antihormonal Cancer Therapies Product

Table 158. Astellas Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 159. Astellas Recent Developments

Table 160. Merck & Co. Company Details

Table 161. Merck & Co. Business Overview

Table 162. Merck & Co. Antihormonal Cancer Therapies Product

Table 163. Merck & Co. Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 164. Merck & Co. Recent Developments

Table 165. Sanofi Company Details

Table 166. Sanofi Business Overview

Table 167. Sanofi Antihormonal Cancer Therapies Product

Table 168. Sanofi Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 169. Sanofi Recent Developments

Table 170. Bayer Company Details

Table 171. Bayer Business Overview

Table 172. Bayer Antihormonal Cancer Therapies Product

Table 173. Bayer Revenue in Antihormonal Cancer Therapies Business (2019-2024) & (US$ Million)

Table 174. Bayer Recent Developments

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antihormonal Cancer Therapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Antihormonal Cancer Therapies Market Share by Type: 2023 VS 2030

Figure 3. Radiations Features

Figure 4. Drugs Features

Figure 5. Surgeries Features

Figure 6. Others Features

Figure 7. Global Antihormonal Cancer Therapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Antihormonal Cancer Therapies Market Share by Application: 2023 VS 2030

Figure 9. Breast Cancer Case Studies

Figure 10. Prostate Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Antihormonal Cancer Therapies Report Years Considered

Figure 13. Global Antihormonal Cancer Therapies Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Antihormonal Cancer Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Antihormonal Cancer Therapies Market Share by Region: 2023 VS 2030

Figure 16. Global Antihormonal Cancer Therapies Market Share by Players in 2023

Figure 17. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihormonal Cancer Therapies as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Antihormonal Cancer Therapies Revenue in 2023

Figure 19. North America Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Antihormonal Cancer Therapies Market Share by Type (2019-2030)

Figure 21. North America Antihormonal Cancer Therapies Market Share by Application (2019-2030)

Figure 22. North America Antihormonal Cancer Therapies Market Share by Country (2019-2030)

Figure 23. United States Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Antihormonal Cancer Therapies Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Antihormonal Cancer Therapies Market Share by Type (2019-2030)

Figure 27. Europe Antihormonal Cancer Therapies Market Share by Application (2019-2030)

Figure 28. Europe Antihormonal Cancer Therapies Market Share by Country (2019-2030)

Figure 29. Germany Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Antihormonal Cancer Therapies Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Antihormonal Cancer Therapies Market Share by Type (2019-2030)

Figure 37. China Antihormonal Cancer Therapies Market Share by Application (2019-2030)

Figure 38. Asia Antihormonal Cancer Therapies Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Antihormonal Cancer Therapies Market Share by Type (2019-2030)

Figure 40. Asia Antihormonal Cancer Therapies Market Share by Application (2019-2030)

Figure 41. Asia Antihormonal Cancer Therapies Market Share by Region (2019-2030)

Figure 42. Japan Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Antihormonal Cancer Therapies Market Share by Country (2019-2030)

Figure 52. Brazil Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Antihormonal Cancer Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Roche Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 59. Amgen Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 60. Samyang Biopharmaceuticals Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 61. Tolmar Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 62. Bluebird Bio Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 64. Exelixis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 65. Guardant Health Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 66. Illumina Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 67. Novartis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 68. Merck KGaA Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 69. AbbVie Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 70. Gilead Sciences Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 71. Johnson & Johnson Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 72. Pfizer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 73. Takeda Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 74. Eli Lilly Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 75. AstraZeneca Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 76. Astellas Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 77. Merck & Co. Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 78. Sanofi Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 79. Bayer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2019-2024)

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

Figure 82. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Breast Cancer Hormone Therapy Market Insights Forecast to 2030

Global Androgen Deprivation Therapy ADT Market Insights Forecast to 2030

Cancer Treatment Drugs Market

Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030

Global Androgen Suppression Therapy Market Insights Forecast to 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Prostate Cancer Hormone Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunotherapy Market Insights Forecast to 2030

Global Cancer Biotherapy Market Insights Forecast to 2030

Global Drugs For Hormonal Replacement Market Insights Forecast to 2030

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Uterine Cancer Therapies and Diagnostic Market Insights Forecast to 2030

Global Chemotherapy Drug Market Insights Forecast to 2030

Global Therapies and Diagnostics for Ovarian Cancer Market Insights Forecast to 2030

Testicular Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hormone Refractory Breast Cancer Market Insights Forecast to 2030

Global Anticancer Drugs Market Research Report 2025

Global Oncology Adjuvants Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions